Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2011-11-23Clinical Trial Update: T-cell Based Immunotherapy for Head and Neck Cancer [Phase 1]
Phase 1 trial of T-cell based immunotherapy for head and neck squamous cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC [Phase 3]
Phase 3 trial assessing accelerated radiotherapy with concomitant chemoradiotherapy for head and neck squamous cell carcinoma has completed.
-
FDA approval · 2011-11-07FDA Approved: ERBITUX — Supplemental Application (ImClone LLC)
The FDA approved a supplemental application for ERBITUX (cetuximab) submitted by ImClone LLC.
-
CLINICAL_TRIALS trial_result · 2011-09-23Clinical Trial Update: Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer [Phase 1]
A Phase 1 study of pemetrexed (Alimta) in patients with head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Imatinib Mesylate (Gleevec) and Docetaxel in patients with head and neck squamous cell …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 2]
Phase 2 trial evaluating the combination of docetaxel and S-1 in head and neck squamous cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating metronomic tegafur/uracil chemotherapy for head and neck squamous cell carcinoma. The current statu…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Phase 2]
Phase 2 study evaluating cetuximab plus concomitant-boost radiotherapy in newly diagnosed locally advanced head and neck squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma [NA]
Clinical trial update describing the assessment of regional tumor response using PET-FDG imaging in advanced head and neck squamous cell car…
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]
This document reports an update on a Phase 2 trial of Pazopanib in patients with recurrent or metastatic head and neck squamous cell carcino…
-
CLINICAL_TRIALS research · 2011-05-17Clinical Trial Update: Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck [Phase 2]
Phase 2 clinical trial update on cisplatin-based chemoradiation with or without cetuximab for locoregionally advanced head and neck squamous…
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase II study evaluating concurrent C225 (cetuximab), cisplatin, and radiation in stage IV head and neck squamous cell carcinoma completed …
-
FDA approval · 2011-03-24FDA Approved: ERBITUX — Supplemental Application (ImClone LLC)
FDA approved a supplemental application for Erbitux (cetuximab) from ImClone LLC, updating or expanding its labeling.
-
CLINICAL_TRIALS research · 2011-03-04Clinical Trial Update: Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma [Phase 2]
This clinical trial update reports on a Phase 2 study comparing accelerated fractionation radiotherapy (AFRT) with concurrent chemoradiother…
-
CLINICAL_TRIALS withdrawal · 2011-01-27Clinical Trial Update: Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A Phase 2 trial of Iressa (gefitinib) with radiotherapy for locally advanced inoperable head and neck squamous cell carcinoma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2, Phase 3]
This clinical trial update discusses the use of Taxotere (docetaxel) as first-line treatment for recurrent/metastatic head and neck squamous…
-
CLINICAL_TRIALS research · 2010-07-28Clinical Trial Update: Trial of E10A in Head and Neck Cancer [Phase 2]
Phase 2 trial update for E10A in head and neck cancer. The diseases covered are head and neck squamous cell carcinoma and nasopharyngeal car…
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck [Phase 1]
A Phase 1 clinical trial update evaluating cisplatin plus gefitinib with re-irradiation in patients with recurrent head and neck squamous ce…
-
CLINICAL_TRIALS research · 2010-03-03Clinical Trial Update: Human Papillomavirus (HPV) in Squamous Cell Carcinoma of the Head and Neck
This is a clinical trial update about human papillomavirus (HPV) involvement in head and neck squamous cell carcinoma, focusing on epidemiol…
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer [Phase 2]
Phase 2 trial comparing lapatinib versus placebo followed by chemoradiation in locally advanced head and neck squamous cell carcinoma has co…
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) [Phase 2]
A Phase 2 trial evaluated neoadjuvant docetaxel, cisplatin, and 5-fluorouracil followed by chemoradiotherapy versus chemoradiotherapy alone …
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial assessing the combination of docetaxel and cisplatin in head and neck squamous cell carcinoma. The stud…
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of the C-TPF chemotherapy regimen in patients with newly diagnosed loca…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]
A Phase 2 trial evaluated the combination of IRESSA (Gefitinib) with cisplatin and radiotherapy in previously untreated, unresected late-sta…
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A Phase 2 study of ARQ 501 in patients with head and neck squamous cell carcinoma has completed.